|
Q3 FY2026
As of Jan 31, 2026
|
Q2 FY2026
As of Oct 31, 2025
|
Q1 FY2026
As of Jul 31, 2025
|
Q4 FY2025
As of Apr 30, 2025
|
Q3 FY2025
As of Jan 31, 2025
|
Q2 FY2025
As of Oct 31, 2024
|
Q1 FY2025
As of Jul 31, 2024
|
Q4 FY2024
As of Apr 30, 2024
|
Q3 FY2024
As of Jan 31, 2024
|
Q2 FY2024
As of Oct 31, 2023
|
Q1 FY2024
As of Jul 31, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 31, 2023
|
Q2 FY2023
As of Oct 31, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
Q4 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Oct 31, 2021
|
Q1 FY2022
As of Jul 31, 2021
|
Q4 FY2021
As of Apr 30, 2021
|
Q3 FY2021
As of Jan 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Notes receivable – related parties | ||||||||||||||||||||
| Purchased technology | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Notes receivable - related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes receivable - related parties | ||||||||||||||||||||
| Purchased technology, net | ||||||||||||||||||||
| Investment in affiliate | ||||||||||||||||||||
| Equity securities at fair value | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Stock subscription payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Current taxes payable | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Related party debt | ||||||||||||||||||||
| Secured note payable | ||||||||||||||||||||
| Short-term promissory notes | ||||||||||||||||||||
| Current portion of SBA loans | ||||||||||||||||||||
| Loan payable - bank | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term SBA loans, less current portion | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term SBA loans, less current portion | ||||||||||||||||||||
| Long term liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $.001 par value; 900,000,000 shares authorized, 6,847,899 and 2,192,226 shares issued and outstanding | ||||||||||||||||||||
| Shares to be issued | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings (deficit) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
